Indaptus Therapeutics
INDP
INDP
5 hedge funds and large institutions have $9.47M invested in Indaptus Therapeutics in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.
Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
NC
1
Nexthera Capital
New York
|
$0 |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
| $4.14M | 809,804 | – | – |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $2.65M | 514,878 | +778 | +0.2% |
|
|
MIFH
3
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
| $2.54M | 497,200 | +497,200 | New |
|
4
Renaissance Technologies
New York
| $66K | 12,944 | +1,744 | +16% |
|
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $65K | 12,724 | +1,524 | +14% |
|
|
NC
6
Nexthera Capital
New York
| – | – | -138,845 | Closed |
|
|
7
UBS Group
Zurich,
Switzerland
| – | – | -875 | Closed |
|